153
Participants
Start Date
November 30, 2012
Primary Completion Date
February 28, 2013
Study Completion Date
August 31, 2013
COV155
COV155 tablets
Charlottesville Medical Research Center, LLC, Charlottesville
The Center for Clinical Research LLC, Winston-Salem
Wake Research Associates LLC, Raleigh
Clinical Study Center of Asheville, LLC, Asheville
Pain Specialists of Charleston, North Charleston
DeGarmo Institute for Medical Research, Greer
Accord Clinical Research, LLC, Port Orange
Lake Internal Medicine Associates, Eustis
International Clinical Research, LLC, Sanford
Clinical Neuroscience Solutions Inc., Orlando
Compass Research, LLC, Orlando
Palm Springs Research Institute, Hialeah
Eastern Research, Hialeah
Martin E. Hale, MD PA (Gold Coast Research LLC), Plantation
Health Awareness, Inc., Jupiter
New Horizons Clinical Research, Cincinnati
Hightop Physicians Inc./Medical Research Center, Cincinnati
Community Research, Cincinnati
Community Research - Anderson, Cincinnati
Goldpoint Clinical Research, Indianapolis
MediSphere Medical Research Center, LLC, Evansville
Health Concepts, Rapid City
Health Research Institute, Oklahoma City
ClinRx Research LLC, Plano
Clinical Trial Network, Houston
Sun Research Institute, San Antonio
FutureSearch Trials of Neurology, LP, Austin
Independent Clinical Researchers, Las Vegas
Torrance Clinical Research Inc., Lomita
Probe Clinical Research Corporation - Santa Ana, Santa Ana
Anaheim Clinical Trials, Anaheim
Orange County Research Institute, Anaheim
United Clinical Research Center, Inc., Anaheim
Beacon Clinical Research, LLC, Brockton
Lead Sponsor
Mallinckrodt
INDUSTRY